Cargando…

The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress

The present study investigates whether hesperetin, a citrus flavonoid, can encounter advanced glycation end-product (AGE)-induced Alzheimer’s disease-like pathophysiological changes with the underlying mechanisms. SH-SY5Y cells pretreated with hesperetin before stimulation with AGEs (200 μg/mL) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Mei-Chou, Liu, Wayne-Young, Liou, Shorong-Shii, Liu, I-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874695/
https://www.ncbi.nlm.nih.gov/pubmed/35215394
http://dx.doi.org/10.3390/nu14040745
_version_ 1784657750445260800
author Lai, Mei-Chou
Liu, Wayne-Young
Liou, Shorong-Shii
Liu, I-Min
author_facet Lai, Mei-Chou
Liu, Wayne-Young
Liou, Shorong-Shii
Liu, I-Min
author_sort Lai, Mei-Chou
collection PubMed
description The present study investigates whether hesperetin, a citrus flavonoid, can encounter advanced glycation end-product (AGE)-induced Alzheimer’s disease-like pathophysiological changes with the underlying mechanisms. SH-SY5Y cells pretreated with hesperetin before stimulation with AGEs (200 μg/mL) were assessed in the following experiments. Hesperetin (40 μmol/L) elevated the reduced cell viability induced by AGEs. Hesperetin ameliorated reactive oxygen species overproduction and the downregulation of superoxide dismutase, glutathione peroxidase, and catalase, triggered by AGEs. Amyloid precursor protein upregulation, accompanied by the increased production of Aβ, caused by AGEs, was reversed by hesperetin. However, hesperetin lowered β-site APP-cleaving enzyme 1 expression, inducing insulin-degrading and neprilysin expression. In addition, hesperetin downregulated the expressions of the AGEs-induced endoplasmic reticulum (ER) stress proteins, including 78-kDa glucose-regulated protein and C/EBP homologous protein, and lowered the phosphorylation of protein kinase R-like ER kinase and activating transcription factor 4. Hesperetin-pretreated cells had a minor apoptotic DNA fragmentation. Hesperetin is able to upregulate Bcl-2 protein expression, downregulate Bax expression, and decrease caspase-12/-9/-3 activity as well, indicating that it inhibits ER stress-mediated neuronal apoptosis. There is a similar effect between hesperetin and positive rosiglitazone control against Aβ aggravation of SH-SY5Y cell injury induced by AGEs. Thus, hesperetin might be a potential agent for treating glycation-induced Aβ neurotoxicity.
format Online
Article
Text
id pubmed-8874695
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88746952022-02-26 The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress Lai, Mei-Chou Liu, Wayne-Young Liou, Shorong-Shii Liu, I-Min Nutrients Article The present study investigates whether hesperetin, a citrus flavonoid, can encounter advanced glycation end-product (AGE)-induced Alzheimer’s disease-like pathophysiological changes with the underlying mechanisms. SH-SY5Y cells pretreated with hesperetin before stimulation with AGEs (200 μg/mL) were assessed in the following experiments. Hesperetin (40 μmol/L) elevated the reduced cell viability induced by AGEs. Hesperetin ameliorated reactive oxygen species overproduction and the downregulation of superoxide dismutase, glutathione peroxidase, and catalase, triggered by AGEs. Amyloid precursor protein upregulation, accompanied by the increased production of Aβ, caused by AGEs, was reversed by hesperetin. However, hesperetin lowered β-site APP-cleaving enzyme 1 expression, inducing insulin-degrading and neprilysin expression. In addition, hesperetin downregulated the expressions of the AGEs-induced endoplasmic reticulum (ER) stress proteins, including 78-kDa glucose-regulated protein and C/EBP homologous protein, and lowered the phosphorylation of protein kinase R-like ER kinase and activating transcription factor 4. Hesperetin-pretreated cells had a minor apoptotic DNA fragmentation. Hesperetin is able to upregulate Bcl-2 protein expression, downregulate Bax expression, and decrease caspase-12/-9/-3 activity as well, indicating that it inhibits ER stress-mediated neuronal apoptosis. There is a similar effect between hesperetin and positive rosiglitazone control against Aβ aggravation of SH-SY5Y cell injury induced by AGEs. Thus, hesperetin might be a potential agent for treating glycation-induced Aβ neurotoxicity. MDPI 2022-02-10 /pmc/articles/PMC8874695/ /pubmed/35215394 http://dx.doi.org/10.3390/nu14040745 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lai, Mei-Chou
Liu, Wayne-Young
Liou, Shorong-Shii
Liu, I-Min
The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress
title The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress
title_full The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress
title_fullStr The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress
title_full_unstemmed The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress
title_short The Citrus Flavonoid Hesperetin Encounters Diabetes-Mediated Alzheimer-Type Neuropathologic Changes through Relieving Advanced Glycation End-Products Inducing Endoplasmic Reticulum Stress
title_sort citrus flavonoid hesperetin encounters diabetes-mediated alzheimer-type neuropathologic changes through relieving advanced glycation end-products inducing endoplasmic reticulum stress
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874695/
https://www.ncbi.nlm.nih.gov/pubmed/35215394
http://dx.doi.org/10.3390/nu14040745
work_keys_str_mv AT laimeichou thecitrusflavonoidhesperetinencountersdiabetesmediatedalzheimertypeneuropathologicchangesthroughrelievingadvancedglycationendproductsinducingendoplasmicreticulumstress
AT liuwayneyoung thecitrusflavonoidhesperetinencountersdiabetesmediatedalzheimertypeneuropathologicchangesthroughrelievingadvancedglycationendproductsinducingendoplasmicreticulumstress
AT lioushorongshii thecitrusflavonoidhesperetinencountersdiabetesmediatedalzheimertypeneuropathologicchangesthroughrelievingadvancedglycationendproductsinducingendoplasmicreticulumstress
AT liuimin thecitrusflavonoidhesperetinencountersdiabetesmediatedalzheimertypeneuropathologicchangesthroughrelievingadvancedglycationendproductsinducingendoplasmicreticulumstress
AT laimeichou citrusflavonoidhesperetinencountersdiabetesmediatedalzheimertypeneuropathologicchangesthroughrelievingadvancedglycationendproductsinducingendoplasmicreticulumstress
AT liuwayneyoung citrusflavonoidhesperetinencountersdiabetesmediatedalzheimertypeneuropathologicchangesthroughrelievingadvancedglycationendproductsinducingendoplasmicreticulumstress
AT lioushorongshii citrusflavonoidhesperetinencountersdiabetesmediatedalzheimertypeneuropathologicchangesthroughrelievingadvancedglycationendproductsinducingendoplasmicreticulumstress
AT liuimin citrusflavonoidhesperetinencountersdiabetesmediatedalzheimertypeneuropathologicchangesthroughrelievingadvancedglycationendproductsinducingendoplasmicreticulumstress